Cognitive enhancers, also known as nootropics, are emerging as promising tools in addiction recovery. These substances aim to improve cognitive functions like memory, attention, and decision-making, which are often impaired by prolonged substance use. Medications such as modafinil, bupropion, and acetylcysteine have shown potential in reducing cravings and supporting cognitive recovery. These drugs work by modulating neurotransmitter systems, including dopamine and glutamate, to restore balance in the brain. Cognitive training programs, combined with these enhancers, further boost recovery outcomes by strengthening executive functions. While research is ongoing, the integration of cognitive enhancers offers a novel dimension to addiction treatment, improving both neurological health and quality of life.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : What to do when a tragedy strikes
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Genetic decoupling and global regulatory failure in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : An unusual perspective for understanding and preventing bulimia relapse: Unhealthy sibling loyalty
Karen Gail Lewis, Private Practice, United States